Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock, $0.00000002 par value
-
Shares outstanding
-
29.5M
-
Number of holders
-
75
-
Total 13F shares, excl. options
-
64.2M
-
Shares change
-
+15.1M
-
Total reported value, excl. options
-
$103M
-
Value change
-
+$22.3M
-
Put/Call ratio
-
0.69
-
Number of buys
-
41
-
Number of sells
-
-29
-
Price
-
$1.61
Significant Holders of MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) as of Q1 2020
89 filings reported holding MEIP - MEI Pharma, Inc. - Common Stock, $0.00000002 par value as of Q1 2020.
MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) has 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 64.2M shares
.
Largest 10 shareholders include Vivo Capital, LLC (9.78M shares), NEA Management Company, LLC (8.53M shares), BlackRock Inc. (5.45M shares), WASATCH ADVISORS INC (5.07M shares), BVF INC/IL (5.05M shares), VANGUARD GROUP INC (4.56M shares), RENAISSANCE TECHNOLOGIES LLC (3.06M shares), PERCEPTIVE ADVISORS LLC (3.03M shares), Burrage Capital Management LLC (3.02M shares), and BOXER CAPITAL, LLC (2.91M shares).
This table shows the top 75 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.